GERN Q2 2021 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena

GERNGeron Corporation

$1B

Q2 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$107,000+148.8% YoY

Gross Profit

-$22M-20401.9% margin

Operating Income

-$29M-26999.1% margin

Net Income

-$30M-27639.3% margin

EPS (Diluted)

$-0.09

QoQ Revenue Growth

-21.9%

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$18M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$252M

Total Liabilities

$76M

Stockholders' Equity

$176M

Cash & Equivalents

$57M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$107,000	$43,000	+148.8%
Gross Profit	-$22M	-$11M	-102.1%
Operating Income	-$29M	-$17M	-72.3%
Net Income	-$30M	-$16M	-86.9%